Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Individuals with multiple sclerosis may have increased risk of developing cancer

Individuals with multiple sclerosis may have an increased risk of developing any type of cancer, with an especially high risk of developing breast cancer. That is the conclusion of a recent study published in European Journal of Neurology. Because the findings contradict earlier studies, additional research is needed to determine whether a true link exists between multiple sclerosis and cancer.

15 Jan 2014

New technology efficiently transfers investigational antibodies from blood via blood-brain barrier

Today the scientific journal Neuron published results on the Roche-designed Brain Shuttle technology that efficiently transfers investigational antibodies from the blood through the blood-brain barrier (BBB) into the brain in preclinical models.

10 Jan 2014

Longer reads: Hospice drains Medicare; false Obamacare 'horror stories;' growing up without vaccines

Hospice patients are expected to die: The treatment focuses on providing comfort to the terminally ill, not finding a cure. To enroll a patient, two doctors certify a life expectancy of six months or less. But over the past decade, the number of "hospice survivors" in the United States has risen dramatically, in part because hospice companies earn more by recruiting patients who aren't actually dying, a Washington Post investigation has found. Healthier patients are more profitable because they require fewer visits and stay enrolled longer (Peter Whoriskey and Dan Keating, 12/26).

9 Jan 2014

Biogen Idec, Sangamo BioSciences partner to develop therapeutics for hemoglobinopathies

Biogen Idec and Sangamo BioSciences, Inc. announced today an exclusive worldwide collaboration and license agreement focused on the development of therapeutics for hemoglobinopathies, inherited conditions that result from the abnormal structure or underproduction of hemoglobin.

9 Jan 2014

Montreal researchers identifies two specific key players in growth of GBM

Glioblastoma (GBM) is the most common and deadly form of primary malignant brain cancer accounting for approximately 15% of all brain tumours and occurring mostly in adults between the ages of 45 and 70.

9 Jan 2014

Epilepsy drug taken during pregnancy not linked with development problems for preschoolers

A new study finds that the epilepsy drug levetiracetam appears not to be associated with thinking, movement and language problems for preschool children born to mothers who took the drug during pregnancy, although the drug valproate was associated with some difficulties in preschoolers.

8 Jan 2014

Apitope-led consortium awarded FP7 Health Innovation funding to develop Graves' disease vaccine

Apitope, the drug discovery and development company focused on treating the underlying cause of autoimmune diseases, today announces that the consortium, led by Apitope, which includes GSK Vaccines, Quintiles and KWS Biotest Limited, has been awarded prestigious Framework Programme 7 Health Innovation funding by the European Commission to develop its Graves' disease therapeutic vaccine, including a Phase I first-in-man study in Graves' disease patients.

8 Jan 2014

IQWiG study finds no added benefit of teriflunomide

Teriflunomide (trade name: Aubagio) has been approved in Germany since August 2013 for adults with relapsing remitting multiple sclerosis. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products, the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over the appropriate comparator therapy specified by the Federal Joint Committee (G-BA).

8 Jan 2014

How Obamacare coverage is shaking out

Even with the health law's insurance options, consumers struggling with chronic diseases may still face such high out-of-pocket costs on some plans that they could have trouble staying out of debt, reports the Associated Press. Meanwhile, several major drugstore chains are offering to fill prescriptions for those who enrolled in new health plans but don't have ID numbers yet.

6 Jan 2014

LA BioMed receives grant to study role of serum Vitamin A in people with multiple sclerosis

Some 2.5 million people around the world have multiple sclerosis (MS), a potentially debilitating disease in which the body's immune system destroys the protective sheath (myelin) that covers nerves.

6 Jan 2014

First Edition: January 6, 2014

Today's headlines include reports about how the health law fits into the Capitol Hill agenda for the year ahead.

6 Jan 2014

Shingles may increase risk of stroke in later life, study finds

Having shingles may increase the risk of having a stroke years later, according to research published in the January 2, 2014, online issue of Neurology, the medical journal of the American Academy of Neurology.

2 Jan 2014

Kessler Foundation to conduct pilot study on improving memory, function in MS patients

Kessler Foundation has been awarded a new grant by the National Multiple Sclerosis Society for a pilot study of memory and learning difficulties in individuals with MS. Scientists will test the effectiveness of using of self-generated learning in a treatment intervention to improve memory and functional performance.

1 Jan 2014

Genzyme gets FDA Complete Response Letter for Lemtrada sBLA

Genzyme, a Sanofi company, announced today that it has received a Complete Response Letter from the U.S. Food and Drug Administration for its supplemental Biologics License Application seeking approval of Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis.

30 Dec 2013

MitoQ antioxidant reverses MS-like disease in animal

Researchers at Oregon Health & Science University have discovered that an antioxidant designed more than a dozen years ago to fight damage within human cells significantly helps symptoms in mice that have a multiple sclerosis-like disease.

27 Dec 2013

Concussion involving momentary loss of consciousness may be related to buildup of Alzheimer's

A new study suggests that a history of concussion involving at least a momentary loss of consciousness may be related to the buildup of Alzheimer's-associated plaques in the brain.

27 Dec 2013

Researchers report new gene delivery method that targets tumor blood vessels

Working in mice, researchers at Washington University School of Medicine in St. Louis report developing a gene delivery method long sought in the field of gene therapy: a deactivated virus carrying a gene of interest that can be injected into the bloodstream and make its way to the right cells.

24 Dec 2013

ANP reports positive interim results from ATL1103 Phase II clinical trial for acromegaly

Antisense Therapeutics Limited is pleased to advise that positive results have been achieved from the interim analysis of a subset of available data from its Phase II clinical trial of ATL1103 in patients with the growth disorder, acromegaly.

23 Dec 2013

European Commission approves update of Erbitux to treat patients with RAS wild-type mCRC

Merck Serono, the biopharmaceutical division of Merck, today announced that the European Commission has approved the Type II variation to amend the Erbitux(cetuximab) product information, updating the indication for Erbitux to the treatment of patients with RAS wild-type metastatic colorectal cancer (mCRC).

23 Dec 2013

Kessler Foundation scientists awarded subcontract to study ways to improve disability statistics

Kessler Foundation scientists John O'Neill, PhD, CRC and Amanda Botticello, PhD, MPH, were awarded a subcontract on the University of New Hampshire's Rehabilitation Research and Training Center grant on Disability Statistics and Demographics. The five-year grant is funded by the National Institute on Disability and Rehabilitation Research under cooperative agreement H133B130015. Economist Andrew Houtenville, PhD, of UNH's Institute on Disability, is project director of the StatsRRTC grant, which totals $4.3 million.

22 Dec 2013

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Individuals with multiple sclerosis may have increased risk of developing cancer

New technology efficiently transfers investigational antibodies from blood via blood-brain barrier

Longer reads: Hospice drains Medicare; false Obamacare 'horror stories;' growing up without vaccines

Biogen Idec, Sangamo BioSciences partner to develop therapeutics for hemoglobinopathies

Montreal researchers identifies two specific key players in growth of GBM

Epilepsy drug taken during pregnancy not linked with development problems for preschoolers

Apitope-led consortium awarded FP7 Health Innovation funding to develop Graves' disease vaccine

IQWiG study finds no added benefit of teriflunomide

How Obamacare coverage is shaking out

LA BioMed receives grant to study role of serum Vitamin A in people with multiple sclerosis

First Edition: January 6, 2014

Shingles may increase risk of stroke in later life, study finds

Kessler Foundation to conduct pilot study on improving memory, function in MS patients

Genzyme gets FDA Complete Response Letter for Lemtrada sBLA

MitoQ antioxidant reverses MS-like disease in animal

Concussion involving momentary loss of consciousness may be related to buildup of Alzheimer's

Researchers report new gene delivery method that targets tumor blood vessels

ANP reports positive interim results from ATL1103 Phase II clinical trial for acromegaly

European Commission approves update of Erbitux to treat patients with RAS wild-type mCRC

Kessler Foundation scientists awarded subcontract to study ways to improve disability statistics

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in